透過您的圖書館登入
IP:18.227.190.93
  • 期刊
  • OpenAccess

Clobazam-induced Stevens-Johnson Syndrome Associated with HLA-B*1502

Clobazam誘發史蒂芬強生症候群與HLA-B*1502之相關

參考文獻


Rattanavipapong W, Koopitakkajorn T, Praditsitthikorn N, Mahasirimongkol S, Teerawattananon Y: Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand. Epilepsia 2013; 54: 1628-38.
Chang CJ: Genotyping HLA-B*1502 and revised drug hazard relief act. Taiwanese Journal of Psychiatry (Taipei) 2011; 25: 123-5.
Wieck HH, Blaha L, Heerklotz B: A clinical view of clobazam. Br J Clin Pharmacol 1979; 7 (Suppl 1): 109S-12S.
Arif H, Buchsbaum R, Weintraub D, et al.: Comparison and predictors of rash associated with 15 antiepileptic drugs. Neurology 2007; 68: 1701-9.
Ertam I, Sezgin AO, Unal I: A case with Stevens Johnson syndrome triggered by combination of clobazam, lamotrigine, and valproic acid treatment. Int J Dermatol 2009; 48: 98-9.

延伸閱讀